Advertisement

Topics

French Company To Expand U.S. Pharma Offering With CDMO Acquisition

06:12 EDT 21 Jun 2018 | Pharmaceutical Processing

Novacap, a pharmaceutical synthesis and advanced specialties company, has signed an agreement to acquire Boston-based PCI Synthesis, a U.S. pharmaceutical contract development and manufacturing organization.
Contributed Author: 
Novacap
Topics: 

Original Article: French Company To Expand U.S. Pharma Offering With CDMO Acquisition

NEXT ARTICLE

More From BioPortfolio on "French Company To Expand U.S. Pharma Offering With CDMO Acquisition"

Advertisement
Quick Search
Advertisement
Advertisement